Aleksandra Kułakowska | Medicine and Health Sciences | Innovative Research Award

Published on by Innovation Technologist

Innovative Research Award

Aleksandra Kułakowska
University of Opole

Aleksandra Kułakowska
Affiliation University of Opole
Country Poland
Documents 9
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0001-5466-7167

Aleksandra Kułakowska is a researcher affiliated with the University of Opole whose scholarly work contributes to contemporary discussions in medicine, public health, patient care, and clinical practice. Her publications explore diverse healthcare topics including nephrology, cardiology, dermatology, women’s health, infection prevention, and quality-of-life assessment. Through peer-reviewed academic articles, she has participated in the dissemination of evidence-based medical knowledge and interdisciplinary healthcare perspectives.[1]

Abstract

This article presents an overview of the academic profile and scholarly contributions of Aleksandra Kułakowska. Her published work addresses clinically relevant healthcare challenges, emphasizing patient well-being, disease management, preventive medicine, and evidence-based healthcare practices. The breadth of topics represented within her publication portfolio demonstrates engagement with multidisciplinary medical research and healthcare education.[2]

Keywords

Medicine, Health Sciences, Clinical Research, Patient Care, Public Health, Dialysis, Medical Education, Healthcare Quality.

Introduction

Healthcare research plays an important role in improving patient outcomes and informing clinical decision-making. Aleksandra Kułakowska’s academic contributions align with this objective by addressing issues related to chronic disease management, healthcare quality, and patient-centered care. Her work contributes to broader efforts aimed at enhancing understanding of medical conditions and treatment outcomes.[3]

Research Profile

The research interests of Aleksandra Kułakowska encompass several areas of medicine and health sciences. Her publications address dialysis and quality of life, mental health implications of chronic treatment, surgical site infection prevention, women’s health, cardiovascular disorders such as Brugada syndrome, and rare dermatological conditions including Schnitzler syndrome. These studies demonstrate interdisciplinary engagement with contemporary healthcare topics.[4]

Research Contributions

  • Evaluation of quality-of-life outcomes among dialysis patients.
  • Assessment of mental health considerations associated with chronic renal therapy.
  • Review of updated guidelines concerning surgical site infections.
  • Analysis of healthy lifestyle interventions for patients experiencing PMS symptoms.
  • Compilation of clinically relevant information regarding Brugada syndrome.

Publications

  • Schnitzler syndrome – a rare cause of chronic urticaria. Case report (2025).
  • What impact does dialysis have on the patient’s life and mental health? (2023).
  • Dialysotherapy effect on the quality of life for renal patients (2023).
  • Surgical site infections – an updated review of guidelines (2023).
  • Holistic care, physical activity and healthy lifestyle in PMS patients (2023).

Research Impact

The published studies contribute to healthcare education and clinical awareness by synthesizing current evidence and discussing practical implications for patient care. Topics such as chronic disease management, infection prevention, and rare disease recognition are relevant to clinicians, healthcare educators, and medical researchers. The diversity of subjects represented in her work reflects a commitment to supporting informed healthcare practice.[5]

Award Suitability

Aleksandra Kułakowska’s scholarly activities align with the objectives of the Global Innovation Technologist Awards by demonstrating engagement with healthcare innovation, medical knowledge dissemination, and interdisciplinary research. Her publication record highlights contributions to clinically relevant topics that support evidence-based practice and ongoing scientific dialogue within medicine and health sciences.[6]

Conclusion

Aleksandra Kułakowska has contributed to a range of healthcare-related subjects through peer-reviewed publications addressing patient outcomes, clinical management, and public health concerns. Her academic portfolio reflects sustained engagement with contemporary medical issues and supports the advancement of healthcare knowledge through scholarly communication.

References

  1. ORCID. (n.d.). Aleksandra Kułakowska ORCID record.
    https://orcid.org/0000-0001-5466-7167
  2. Oxford Medical Case Reports. (2025). Schnitzler syndrome – a rare cause of chronic urticaria. Case report.
    DOI: https://doi.org/10.1093/omcr/omaf118
  3. Journal of Education, Health and Sport. (2023). What impact does dialysis have on the patient’s life and mental health?
    DOI: https://doi.org/10.12775/JEHS.2023.39.01.001
  4. Journal of Education, Health and Sport. (2023). Dialysotherapy effect on the quality of life for renal patients.
    DOI: https://doi.org/10.12775/JEHS.2023.28.01.006
  5. Journal of Education, Health and Sport. (2023). Surgical site infections – an updated review of guidelines in the light of new scientific data.
    DOI: https://doi.org/10.12775/JEHS.2023.28.01.002
  6. Journal of Education, Health and Sport. (2023). Concise compilation of the most clinically relevant current knowledge on Brugada Syndrome.
    DOI: https://doi.org/10.12775/JEHS.2023.25.01.001

Lenin Martínez | Medicine and Health Sciences | Innovative Research Award

Published on by Innovation Technologist

Innovative Research Award

Lenin Martínez
UIDE, Ecuador
Lenin Martínez
Affiliation UIDE
Country Ecuador
Documents 1
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
ORCID 0009-0007-6404-4386

Lenin Martínez is an Ecuadorian dental researcher and emerging academic contributor associated with UIDE. His scholarly interests focus on dentistry, oral hygiene education, innovation in preventive healthcare, and the use of digital communication technologies for public health awareness. His recent publication examining oral hygiene misinformation on social media platforms contributes to ongoing discussions regarding digital health literacy and evidence-based dental communication.[1]

Abstract

This article documents the academic profile and research contributions of Lenin Martínez in the field of dentistry and oral health communication. His work emphasizes preventive dental education and the influence of digital media on public understanding of oral hygiene practices. Martínez has explored the relationship between online health content and professional clinical standards, particularly through the evaluation of educational materials distributed on social platforms.[2]

Keywords

Dentistry, innovation, education, prevention, technology, oral hygiene, digital health communication, misinformation.

Introduction

Contemporary dentistry increasingly intersects with digital communication technologies and public health education. Researchers examining oral hygiene awareness across online environments contribute to the development of evidence-based educational standards. Lenin Martínez has participated in this emerging research area through investigations focused on oral health communication and misinformation within social media ecosystems.[3]

Research Profile

Martínez studied dentistry at Universidad Internacional del Ecuador and has maintained academic involvement connected to the institution since 2020. His professional orientation combines preventive dentistry, ethical patient care, and oral health education. His research profile reflects an interdisciplinary perspective integrating healthcare communication, educational methodology, and clinical awareness.[1]

Research Contributions

One of Martínez’s notable contributions involves the analysis of TikTok as a source of oral hygiene information. The study assessed whether content distributed through social media aligns with recognized dental guidelines and explored the prevalence of misinformation related to oral hygiene practices. This research contributes to broader discussions regarding healthcare literacy, digital communication ethics, and preventive public health strategies.[4]

  • Evaluation of social media dental education content.
  • Promotion of evidence-based oral hygiene practices.
  • Research on misinformation and preventive healthcare communication.

Publications

  • TikTok as a Source of Oral Hygiene Education: Alignment and Misinformation Relative to Official Dental Guidelines. Hygiene, 2026.

Research Impact

The increasing reliance on social media platforms for healthcare information has generated academic interest regarding content quality and reliability. Martínez’s research addresses these concerns by evaluating digital oral hygiene education against established professional recommendations. Such studies support the advancement of preventive healthcare communication and encourage critical evaluation of online medical content.[5]

Award Suitability

The Innovative Research Award recognizes emerging scholars whose work demonstrates originality, practical relevance, and interdisciplinary engagement. Martínez’s research aligns with these objectives through its focus on preventive dentistry, educational technology, and digital health communication. His work reflects the evolving relationship between healthcare practice and online information systems, making his contributions relevant to contemporary public health discourse.[6]

Conclusion

Lenin Martínez represents an emerging academic voice in dentistry and digital health education. Through research exploring oral hygiene communication on social media, he contributes to discussions surrounding misinformation, preventive healthcare, and evidence-based patient education. His scholarly activities support the goals of innovation-oriented academic recognition within medicine and health sciences.

References

  1. ORCID. (2026). Lenin Alejandro Martinez Rosero professional profile and affiliation details.
    orcid.org/0009-0007-6404-4386
  2. MDPI. (2026). Hygiene journal publication metadata and article indexing.
  3. Universidad Internacional del Ecuador. (n.d.). Academic and institutional information relating to dentistry studies.
  4. Martinez Rosero, L. A. (2026). TikTok as a Source of Oral Hygiene Education: Alignment and Misinformation Relative to Official Dental Guidelines.
    doi.org/10.3390/hygiene6020026
  5. Elsevier. (n.d.). Digital health communication and oral healthcare education research indexing.
  6. Global Innovation Technologist Awards. (2026). Award categories and innovation recognition framework.
    innovationtechnologist.com

Dominic Richmond | Health Professions | Best Researcher Award

Published on by Innovation Technologist

Best Researcher Award

Dominic Richmond
University of Birmingham, United Kingdom
Dominic Richmond
Affiliation University of Birmingham
Country United Kingdom
Scopus ID 57189870953
Documents 2
Citations 32
h-index 2
Subject Area Health Professions
Event Global Innovation Technologist Awards
ORCID 0009-0001-9270-937X

Dominic Richmond is a United Kingdom-based physiotherapy researcher and advanced clinical practitioner associated with the University of Birmingham and Cambridge University Hospitals NHS Foundation Trust. His academic and clinical work focuses on musculoskeletal rehabilitation, anterior cruciate ligament (ACL) injury management, sports physiotherapy, and evidence-based rehabilitation practices. Richmond has contributed to clinical research addressing return-to-sport outcomes and musculoskeletal injury prevention within elite athletic and healthcare environments.[1] His profile reflects a combination of academic achievement, clinical leadership, and interdisciplinary healthcare research aligned with contemporary health professions scholarship.[2]

Abstract

This article presents an academic overview of Dominic Richmond, a physiotherapist and healthcare researcher whose work has contributed to sports medicine, musculoskeletal rehabilitation, and anterior cruciate ligament research. Richmond’s clinical and academic activities integrate evidence-based rehabilitation methods with applied healthcare delivery in hospital and elite sporting environments. His published work and conference contributions demonstrate continuing engagement with ACL rehabilitation pathways, return-to-sport assessment methodologies, and injury risk mitigation strategies.[3] The profile also highlights his participation in healthcare leadership, interdisciplinary clinical practice, and research-oriented physiotherapy education.[4]

Keywords

Health Professions, Physiotherapy, ACL Rehabilitation, Sports Medicine, Musculoskeletal Research, Evidence-Based Practice, Clinical Rehabilitation, Knee Injury Research, Return-to-Sport Testing, Advanced Physiotherapy Practice

Introduction

Contemporary healthcare systems increasingly emphasize interdisciplinary rehabilitation, injury prevention, and evidence-informed physiotherapy interventions. Within this context, clinicians engaged in both practical and academic healthcare activities contribute significantly to the development of patient-centered rehabilitation frameworks. Dominic Richmond’s professional profile illustrates the integration of advanced physiotherapy practice with sports medicine research and musculoskeletal healthcare delivery.[5]

Richmond has worked across clinical, academic, and elite sports environments, including orthopaedic clinics, rehabilitation programs, and research-focused healthcare initiatives. His involvement with Cambridge University Hospitals NHS Foundation Trust and postgraduate studies at the University of Birmingham reflects continued engagement with advanced clinical reasoning, healthcare education, and translational rehabilitation research.[2]

Research Profile

Dominic Richmond’s research profile centers on physiotherapy, sports rehabilitation, and musculoskeletal injury management. His Scopus author profile records publications and citations related to ACL rehabilitation and return-to-sport methodologies.[1] His research interests include knee rehabilitation, strength and conditioning, injury prevention, and evidence-based physiotherapy interventions.

In addition to peer-reviewed publications, Richmond has participated in scientific conferences including the European College of Sport Science and UK Strength and Conditioning Association meetings. These activities demonstrate engagement with international scientific communication and collaborative research dissemination.[6]

  • Advanced Practice Physiotherapist specializing in knee rehabilitation and ACL pathways
  • Research involvement in sports medicine and return-to-sport evaluation
  • Participation in NIHR Health and Care Professional Internship Programme
  • Contributor to musculoskeletal physiotherapy education and clinical supervision

Research Contributions

Richmond has contributed to research examining injury rehabilitation strategies and musculoskeletal performance outcomes. His published and presented work includes investigations into ACL rehabilitation pathways and muscle-tendon mechanics associated with eccentric training interventions.[7]

His research collaborations have explored risk factors associated with sports-related injuries and return-to-sport testing after ACL reconstruction. These studies contribute to ongoing discussions concerning rehabilitation quality, athlete recovery, and evidence-based physiotherapy practice.[8]

  • Research on ACL injury priorities among at-risk female populations
  • Systematic review and meta-analysis related to return-to-sport testing
  • Conference presentations involving muscle-tendon mechanics and eccentric training
  • Clinical audit and healthcare improvement initiatives in musculoskeletal services

Publications

  1. Richmond, D., White, C., & Gomulko, T. Pass Rates of Return to Sport Test Batteries Following Anterior Cruciate Ligament Reconstruction: A Systematic Review and Meta-Analysis. Sports, 2026.
  2. Kay, A.D., Richmond, D., Talbot, C., Mina, M., Baross, A.W., & Blazevich, A.J. Stretching of Active Muscle Elicits Chronic Changes in Multiple Strain Risk Factors. Medicine & Science in Sports & Exercise, 2016.
  3. Research priorities for ACL injuries in at-risk groups – The female population. Published in Knee, 2025.[1]

Research Impact

Richmond’s academic output demonstrates measurable engagement within sports medicine and physiotherapy literature. According to Scopus metrics, his publications have received scholarly citations that reflect emerging influence within musculoskeletal rehabilitation research.[1] His work addressing ACL rehabilitation contributes to contemporary discussions concerning rehabilitation benchmarks, athlete recovery standards, and evidence-informed return-to-sport assessments.

Beyond publication metrics, Richmond’s research impact is reinforced by his participation in healthcare leadership programs, conference presentations, and integration of research findings into clinical rehabilitation pathways. Such contributions support broader healthcare objectives focused on patient outcomes, rehabilitation quality, and multidisciplinary collaboration.[4]

Award Suitability

Dominic Richmond’s professional and academic profile aligns with the objectives commonly associated with the Best Researcher Award within the Global Innovation Technologist Awards framework. His combined contributions to clinical physiotherapy, musculoskeletal rehabilitation research, healthcare education, and interdisciplinary sports medicine demonstrate engagement with both scientific inquiry and applied healthcare innovation.[9]

The integration of evidence-based rehabilitation methods into advanced clinical practice, alongside conference participation and peer-reviewed publications, reflects sustained commitment to healthcare advancement. His role in ACL rehabilitation leadership and musculoskeletal clinical services further supports recognition within professional health professions awards programs.[5]

Conclusion

Dominic Richmond represents an emerging contributor within physiotherapy and sports rehabilitation research. His academic publications, clinical leadership activities, and participation in healthcare-focused research initiatives collectively demonstrate ongoing engagement with musculoskeletal rehabilitation science and evidence-based healthcare practice. Through collaborative research, advanced clinical service delivery, and scholarly dissemination, Richmond contributes to the evolving landscape of health professions and rehabilitation medicine.[3]

References

  1. Elsevier. (n.d.). Scopus author details: Dominic Richmond, Author ID 57189870953. Scopus.
    www.scopus.com/authid/detail.uri?authorId=57189870953
  2. University of Birmingham. (2025). Academic and professional profile associated with advanced physiotherapy studies and healthcare practice.
  3. ORCID. (2026). Dominic Richmond ORCID Profile.
    orcid.org/0009-0001-9270-937X
  4. Cambridge University Hospitals NHS Foundation Trust. (2026). Advanced Practice Physiotherapy and rehabilitation leadership activities.
  5. Richmond, D. (2026). Clinical rehabilitation and ACL management contributions in musculoskeletal healthcare.
  6. European College of Sport Science. (2013). Conference proceedings and research presentation abstracts involving muscle-tendon mechanics.
  7. Kay, A.D., Richmond, D., Talbot, C., Mina, M., Baross, A.W., & Blazevich, A.J. (2016). Stretching of Active Muscle Elicits Chronic Changes in Multiple Strain Risk Factors. Medicine & Science in Sports & Exercise.
  8. Richmond, D., White, C., & Gomulko, T. (2026). Pass Rates of Return to Sport Test Batteries Following Anterior Cruciate Ligament Reconstruction: A Systematic Review and Meta-Analysis. Sports.
    doi.org/10.3390/sports14050211
  9. Global Innovation Technologist Awards. (2026). International recognition framework for innovation and research excellence.
    innovationtechnologist.com

Mutinda Cleophas Kyama | Medicine and Health Sciences | Research Excellence Award

Published on by Innovation Technologist

Research Excellence Award

Cleophas Mutinda Kyama
Jomo Kenyatta University of Agriculture and Technology, Kenya
Cleophas Mutinda Kyama
Affiliation Jomo Kenyatta University of Agriculture and Technology
Country Kenya
Scopus ID 57216717397
Documents 65
Citations 2,698
h-index 29
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0001-6459-1514

Cleophas Mutinda Kyama is a Kenyan biomedical scientist, clinical cytologist, and academic researcher associated with the Jomo Kenyatta University of Agriculture and Technology (JKUAT). His scholarly contributions span cancer biology, molecular diagnostics, parasitology, toxicology, infectious disease detection, and translational biomedical sciences. His publication record demonstrates sustained engagement in interdisciplinary health science research with applications in oncology, infectious diseases, immunology, and molecular medicine.[1] The researcher has received significant scholarly attention through citations and collaborative biomedical investigations, particularly in cervical cancer diagnostics, phytomedicine, CRISPR-based diagnostic technologies, and antivenom development.[2]

Abstract

The Research Excellence Award recognition article documents the scholarly achievements and biomedical research contributions of Cleophas Mutinda Kyama. His scientific portfolio encompasses molecular diagnostics, oncology, pharmacological investigations, parasitology, immunological research, and translational health sciences. Through peer-reviewed publications, collaborative international research, and laboratory-based innovations, Kyama has contributed to the advancement of diagnostic technologies and therapeutic investigations relevant to public health challenges in Africa and globally.[3] The researcher’s work demonstrates integration of computational biology, molecular docking, in vitro experimentation, and nanotechnology-assisted diagnostics, reflecting contemporary interdisciplinary scientific approaches.[4]

Keywords

Biomedical Sciences; Molecular Diagnostics; Cervical Cancer Research; CRISPR-Cas12a; Oncology; Cytology; Antivenom Research; Pharmacology; Translational Medicine; Public Health Research; Cancer Therapeutics; Computational Biology.

Introduction

Biomedical and translational health sciences have increasingly relied upon interdisciplinary approaches integrating molecular biology, computational modeling, immunology, and experimental medicine. Within this scientific landscape, Cleophas Mutinda Kyama has contributed to research efforts addressing infectious diseases, cancer diagnostics, toxicology, and therapeutic screening technologies.[5] His work has emphasized practical healthcare applications, particularly within African biomedical contexts where diagnostic accessibility and disease management remain major public health priorities.

Kyama’s research trajectory demonstrates sustained engagement in clinically relevant investigations involving HPV-associated cervical cancer screening, SARS-CoV-2 detection systems, phytochemical anticancer studies, and venom toxicology. Several of his investigations combine computational methodologies with laboratory validation, contributing to evidence-based biomedical innovation and translational healthcare research.[6]

Research Profile

Cleophas Mutinda Kyama served at Jomo Kenyatta University of Agriculture and Technology as a Biomedical Scientist and Senior Lecturer in Medical Laboratory Sciences. His academic and professional work has focused on laboratory diagnostics, cytology, cancer biology, molecular therapeutics, and pathogen detection technologies.[1]

The researcher’s Scopus profile reports 65 scholarly documents with 2,698 citations and an h-index of 29, reflecting measurable scientific visibility and sustained citation impact across biomedical disciplines.[1] His work has appeared in journals including PLOS ONE, BMC Complementary Medicine and Therapies, Diagnostics, Toxicon: X, Toxins, and the South African Journal of Botany.

  • Research specialization in molecular diagnostics and biomedical laboratory sciences.
  • Interdisciplinary research combining computational biology and experimental medicine.
  • Published investigations involving oncology, toxicology, parasitology, and virology.
  • Contributions to public health-oriented biomedical innovation.

Research Contributions

Among Kyama’s notable scientific contributions are investigations into cervical cancer therapeutics and molecular screening technologies. His 2025 study in PLOS ONE explored the molecular mechanisms of Solanecio mannii aqueous root extracts against cervical cancer using computational and experimental validation methodologies.[2]

Additional research explored network pharmacology and molecular docking strategies for prostate cancer treatment investigations using Aspilia pluriseta. These studies integrated in vitro analysis with computational biology techniques to evaluate antiproliferative activity and potential therapeutic mechanisms.[3]

Kyama also contributed to advanced infectious disease diagnostics through CRISPR-Cas12a and hybridization chain reaction methodologies for SARS-CoV-2 detection. This work reflected the growing importance of rapid molecular diagnostic systems during global public health emergencies.[4]

In toxicological and immunological sciences, his studies investigated venom lethality, monoclonal antibody development, and antivenom efficacy involving Naja ashei toxins. These investigations contributed to understanding envenomation management and toxin-neutralizing biomedical strategies.[7]

Publications

Selected publications associated with Cleophas Mutinda Kyama include peer-reviewed journal articles, preprints, and translational biomedical studies relevant to oncology, diagnostics, toxicology, and parasitology.

  1. Computational investigation and experimental validation of the molecular mechanism of Solanecio mannii aqueous roots extract against cervical cancer. PLOS ONE (2025).
  2. Network pharmacology, molecular docking, and in vitro study on Aspilia pluriseta against prostate cancer. BMC Complementary Medicine and Therapies (2024).
  3. Application of Hybridization Chain Reaction/CRISPR-Cas12a for the Detection of SARS-CoV-2 Infection. Diagnostics (2023).
  4. Evaluation of lethality and cytotoxic effects induced by Naja ashei venom and efficacy of selected antivenoms in Kenya. Toxicon: X (2022).
  5. Development and Characterization of Anti-Naja ashei Three-Finger Toxins-Specific Monoclonal Antibodies. Toxins (2022).

Research Impact

The scientific impact of Cleophas Mutinda Kyama’s work is reflected through citation metrics, interdisciplinary collaborations, and practical biomedical applications. His investigations into molecular diagnostics and therapeutic evaluation contribute to contemporary discussions surrounding affordable healthcare technologies, precision diagnostics, and evidence-based medicinal research.[4]

Research involving CRISPR-based diagnostics and nanoparticle-assisted detection systems demonstrates alignment with emerging biomedical technologies that support rapid pathogen identification and translational healthcare innovation.[8] Similarly, his toxicological and antivenom studies address healthcare concerns related to snakebite management in endemic regions.

The integration of phytomedicine, computational molecular analysis, and laboratory validation techniques further reflects a multidisciplinary scientific framework capable of supporting future biomedical innovation and collaborative translational research initiatives.[3]

Award Suitability

The scholarly profile of Cleophas Mutinda Kyama demonstrates characteristics associated with international academic recognition and research excellence awards. His documented publication history, citation impact, interdisciplinary biomedical investigations, and sustained engagement in translational health sciences collectively support recognition within the framework of the Global Innovation Technologist Awards.[1]

  • Demonstrated publication productivity in indexed scientific journals.
  • Strong citation impact and measurable academic influence.
  • Contributions to molecular diagnostics and translational medicine.
  • Interdisciplinary biomedical innovation relevant to public health.
  • Research engagement involving computational and experimental methodologies.

Conclusion

Cleophas Mutinda Kyama has established a research profile characterized by interdisciplinary biomedical inquiry, molecular diagnostic innovation, and translational scientific investigations addressing major health challenges. His academic contributions in oncology, toxicology, molecular biology, and infectious disease diagnostics demonstrate sustained scholarly engagement and measurable scientific impact.[5] Through collaborative biomedical research and publication activity, his work contributes to evolving scientific understanding within medicine and health sciences while supporting broader healthcare research objectives relevant to emerging global health priorities.

References

  1. Elsevier. (n.d.). Scopus author details: Cleophas Mutinda Kyama, Author ID 57216717397. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57216717397
  2. Kyama, C. M. et al. (2025). Computational investigation and experimental validation of the molecular mechanism of Solanecio mannii aqueous roots extract against cervical cancer. PLOS ONE.
    https://doi.org/10.1371/journal.pone.0323680
  3. Kyama, C. M. et al. (2024). Network pharmacology, molecular docking, and in vitro study on Aspilia pluriseta against prostate cancer. BMC Complementary Medicine and Therapies.
    https://doi.org/10.1186/s12906-024-04642-8
  4. Kyama, C. M. et al. (2023). Application of Hybridization Chain Reaction/CRISPR-Cas12a for the Detection of SARS-CoV-2 Infection. Diagnostics.
    https://doi.org/10.3390/diagnostics13091644
  5. Jomo Kenyatta University of Agriculture and Technology. (n.d.). Medical Laboratory Sciences and Biomedical Research Activities.
  6. Kyama, C. M. et al. (2022). Expression of the Fab enzymes from Plasmodium falciparum after exposure to Artemisia afra plant extracts. Journal of Parasitic Diseases.
    https://doi.org/10.1007/s12639-022-01537-8
  7. Kyama, C. M. et al. (2022). Development and Characterization of Anti-Naja ashei Three-Finger Toxins-Specific Monoclonal Antibodies. Toxins.
    https://doi.org/10.3390/toxins14040285
  8. Kyama, C. M. et al. (2020). Development of HPV 16/18 E6 oncoprotein paper-based nanokit for enhanced cervical cancer screening.
    https://doi.org/10.1101/2020.04.29.20084459

Catherine Frenkel | Medicine and Health Sciences | Research Excellence Award

Published on by Innovation Technologist

Dr. Catherine Frenkel | Medicine and Health Sciences | Research Excellence Award

Levine Cancer Institute | United States

Dr. Catherine Frenkel is a surgeon-scientist specializing in head and neck oncology, surgical innovation, and clinical ethics. Her research integrates oncologic outcomes with ethical frameworks, particularly in areas such as robotic surgery, telesurgery, and decision-making in complex cancer care. She has contributed significantly to enhanced recovery after surgery (ERAS) protocols and multidisciplinary cancer treatment optimization. Her work also explores ethical challenges in transplantation and AI integration in surgical practice. Dr. Catherine Frenkel is actively involved in clinical research as a principal investigator, focusing on improving patient outcomes and healthcare delivery through evidence-based and ethically grounded innovations in surgical oncology.

                            Citation Metrics (Scopus)

300

250

200

150

100

50

0

 

Citations
197
Documents
20
h-index
7

Citations

Documents

h-index

View Scopus Profile  View Google Scholar Profile  View ORCID Profile

Featured Publications

Fan Zhou | Immunology and Microbiology | Research Excellence Award

Published on by Innovation Technologist

Dr. Fan Zhou | Immunology and Microbiology | Research Excellence Award

Associate Chief Physician | Nanjing Drum Tower Hospital | China

Dr. Fan Zhou is a clinician-scientist specializing in inflammatory bowel disease and gastric cancer, with a strong focus on the immune microenvironment and tumor immune escape mechanisms. His research integrates molecular immunology with translational medicine to identify pathways that drive cancer progression and inflammation-related disease. He has authored multiple peer-reviewed publications in leading international journals across oncology and immunology. As a principal investigator and contributor to nationally and provincially funded projects, his work advances mechanistic understanding and supports the development of personalized therapeutic strategies with clear clinical relevance.

Citation Metrics (Orcid)

10

8

6

4

2

0

Citations
9

Document 1

Citations

Document


View ORCID Profile

Tadesse Tarik Tamir | Medicine | Editorial Board Member

Published on by Innovation Technologist

Mr. Tadesse Tarik Tamir | Medicine | Editorial Board Member

Senior Lecturer at College of Medicine and Health Sciences, University of Gondar | Ethiopia

Mr. Tadesse Tarik Tamir is a dedicated scholar and lecturer in Pediatrics and Child Health Nursing at the University of Gondar, Ethiopia, with a strong research footprint in maternal and child health. He has authored more than 65 peer-reviewed publications, contributing extensively to areas such as neonatal and infant mortality, childhood nutrition, immunization coverage, maternal vaccination, and pediatric mental health. His work is characterized by rigorous analytical approaches, including spatial, multilevel, and hierarchical modeling applied to large demographic and health survey datasets across Africa. Tadesse’s research offers critical insights into public health challenges affecting vulnerable populations, particularly mothers, infants, and young children in low- and middle-income settings. In addition to his academic role, he actively supports knowledge generation through teaching and community engagement, fostering a supportive environment for emerging researchers. Currently advancing his expertise through studies in epidemiology, he demonstrates a strong commitment to evidence-based practice and interdisciplinary collaboration. His contributions continue to inform policy, improve health service delivery, and shape interventions aimed at reducing preventable morbidity and mortality among children and women across sub-Saharan Africa.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

Tamir, T. T., Zegeye, A. F., Workneh, B. S., Ali, M. S., Gonete, A. T., Techane, M. A., Wassie, M., Kassie, A. T., Ahmed, M. A., & Tsega, S. S., et al. (2025). Childhood wasting and associated factors in Africa: Evidence from standard demographic and health surveys from 35 countries. BMC Public Health.

Tamir, T. T., Tekeba, B., Techane, M. A., Alemu, T. G., Wubneh, C. A., & Wassie, Y. A. (2025). Coverage of complete basic childhood vaccination and its variation by basic characteristics among children aged 12–23 months in 41 low- and middle-income countries: A meta-analysis of demographic and health survey reports between 2015 and 2025. Vaccine.

Kassie, A. T., Zegeye, A. F., Bazezew, A. M., Mamo, E. Y., Gebru, D. M., & Tamir, T. T. (2025). Determinants of pressure to conceive among reproductive age women in sub-Saharan Africa: A multilevel analysis of recent demographic and health surveys in five countries. PLOS Global Public Health.

Mekonen, E. G., Workneh, B. S., Zegeye, A. F., & Tamir, T. T. (2025). Only three out of ten women received adequate postnatal care in sub-Saharan Africa: Evidence from 20 countries demographic and health surveys (2015–2022). BMC Pregnancy and Childbirth.

Tekeba, B., Tamir, T. T., & Zegeye, A. F. (2025). Prevalence and determinants of full vaccination coverage according to the national schedule among children aged 12–35 months in Ghana. Scientific Reports.

Monika Prakash | Medical Biotechnology | Best Researcher Award

Published on by Innovation Technologist

Dr. Monika Prakash | Medical Biotechnology | Best Researcher Award

Assistant Professor at Ramaiah Institute of Technology, India

Dr. Monika P is an accomplished academician and researcher with a focus on biotechnology, particularly in cell biology, nanobiotechnology, and wound healing. She is currently an Assistant Professor at the Department of Biotechnology, MS Ramaiah Institute of Technology (MSRIT), Bengaluru, where she has been teaching since November 2016. She has over 7 years of research experience and has contributed significantly to the development of novel therapeutic solutions for chronic wound healing, including research on fibroblasts, myofibroblasts, and phytocompounds.

Publication Profile 

Scopus

Educational Background 🎓

  • Ph.D. in Biotechnology, Visvesvaraya Technological University (VTU), Belagavi, 2023
  • M.Tech in Biotechnology, M.S. Ramaiah Institute of Technology (Autonomous Institute Affiliated to VTU), Bengaluru, 2014, CGPA: 9.43 (Second topper)
  • B.E. in Biotechnology, M.S. Ramaiah Institute of Technology, Bengaluru, 2011, CGPA: 8.8
  • P.U.C. (12th Standard), Maharani Lakshmi Ammanni College, Bengaluru, 2007, 83.5%
  • S.S.L.C. (10th Standard), Nirmala Rani High School, Bengaluru, 2005, 90.72%

Professional Experience 💼

  • Assistant Professor, Department of Biotechnology, MSRIT, Bengaluru, Nov 2016–Present
  • Over 8 years of teaching experience in various biotechnology-related courses
  • Guided multiple undergraduate and postgraduate student projects in fields like tissue engineering, nanobiotechnology, and chronic wound healing

Research Interests 🔬

  • Cell Biology & Cell Culture: Specialization in fibroblasts, myofibroblasts, and their role in wound healing.
  • Nanobiotechnology: Development of novel nanoformulations and scaffolds, especially for medical applications like chronic wound healing.
  • Phytocompounds: Investigating plant-based compounds for their therapeutic potential in wound healing, particularly for diabetic foot ulcers and burn wounds.
  • Chronic Wound Healing: Focus on developing low-cost, effective solutions for enhancing wound regeneration, especially for non-healing ulcers.

Awards and Honors🏆✨

  • Young Women Research Award (2025), Venus International Foundation
  • Certificate of Excellence for completing “Certified Peer Reviewer Course” from Elsevier Researcher Academy (2021)
  • Best Paper Presentation Award at the International Conference on Functional Materials, Energy, Environment, and Biomedical Applications (2022)
  • Best UG Project Award (2022) and other recognitions for mentoring top student projects
  • Best Technical Project Award from the Government of Karnataka for “Development of Nano-catechin for enhanced Bioavailability” (2014)
  • Publons Academy Graduate (2021), first from the institute

Conclusion🌟

Dr. Monika P is a dynamic academician and researcher with a passion for advancing biotechnology research, particularly in the realm of nanobiotechnology and chronic wound healing. Her strong academic background, extensive research experience, and dedication to student mentorship make her a significant contributor to the field of biotechnology. She has consistently earned recognition for her work and continues to foster innovation in her research and teaching. Through various collaborations and funded research projects, Dr. Monika P is paving the way for advancements in wound healing therapies and sustainable healthcare solutions.

Publications 📚

1. 📝 Monika, Prakash, Anushka Poola, Prithvi Prabhu, Samrat K.
“Key insights into recent advances and challenges in COVID‑19 Management”
Discover Public Health (2025) 22: 15.

2. 🧪 P. Monika, M. N. Chandraprabha, R. Hari Krishna, Vittal Maanya, C. Likhitha, N. Pooja.
“Development of targeted nanocapsules using pomegranate peel extract with enhanced bioavailability and anti-inflammatory activity for ulcerative colitis: In vitro studies”
Hybrid Advances, 2024.

3. 🔬 Prakash Monika, Hari Krishna Rajan, Chandraprabha MN, Sakshi Shetty, Tanushka Mukherjee, S. Girish Kumar.
“Recent Developments in Green Synthesis of Hydroxyapatite Nanocomposites: Relevance to Biomedical and Environmental Applications”
Green Chemistry Letters and Reviews, 2024 (IF- 6.6, Q1)

4. 💉 Prakash, M. N. Chandraprabha, Vivek Radhakrishnan, Prathik Somayaji, Leah Sabu.
“Therapeutic potential of silkworm sericin in wound healing applications.”
Wound Repair and Regeneration, 2024 (IF-3.8, Q1, H-index – 133).

5. 🧑‍🔬 Monika Prakash, M.N. Chandraprabha, R. Hari Krishna, Harini Satish, S. Girish Kumar.
“Iron oxide nanoparticles for inflammatory bowel disease: Recent advances in diagnosis and targeted drug therapy.”
Applied Surface Science Advances. 2024, 19: 100540 (IF- 7.8, Q1).

6. 🔩 Gowda, Charishma C.; B., Lavanya; M. N., Chandra Prabha; Krishna, R. Hari; P., Monika.
“Bioceramics in Hip and Knee Implants.”
Journal of Mines, Metals & Fuels. 2023, 71 (3): 400-407. (Q4)

7. 🌿 Monika, Prakash, M. N. Chandraprabha, and K. N. Murthy.
“Catechin, epicatechin, curcumin, garlic, pomegranate peel and neem extracts of Indian origin showed enhanced anti-inflammatory potential in human primary acute and chronic wound derived fibroblasts by decreasing TGF-β and TNF-α expression.”
BMC Complementary Medicine and Therapies 23, no. 1 (2023): 1-16. (IF- 3.78, Q1)

8. 🧬 Monika, Prakash, M. N. Chandraprabha, KN Chidambara Murthy, P. Veena Waiker, and Annapoorni Rangarajan.
“Standardized ready-to-use laboratory protocol to isolate primary human wound associated fibroblasts from infected wound samples for clinical applications.”
Journal of Microbiological Methods (2023): 106712. (IF- 2.5, Q3)

9. 🧫 Monika, Prakash, M. N. Chandraprabha, and KN Chidambara Murthy.
“Gene expression studies in primary human acute and chronic wound fibroblasts treated with most popular wound healing phytoextracts.”
South African Journal of Botany 155 (2023): 205-213. (IF- 3.11, Q2).

10. 🔬 Krishna, R. Hari, M. N. Chandraprabha, Prakash Monika, Vishal Chaudhary, and C. Manjunatha.
“Biomolecule conjugated inorganic nanoparticles for biomedical applications: A review.”
Biotechnology and Genetic Engineering Reviews (2022): 1-42. (IF- 4.5, Q1).